Erken doğum riski ve tahmini

Erken doğum insidansı giderek artmakta ve neonatal mortalite ve morbiditenin en önemli nedeni olmaya de-vam etmektedir. Erken doğumlar enfeksiyon, inflamas- yon, vasküler hastalıklar ve uterusun aşırı genişlemesi gibi birçok nedeni olan bir sendrom olarak kabul edil-mektedir. Multifaktöriyel etyolojisinden dolayı erken do- ğum riski olan kadınları belirlemek zordur. Erken doğum çoğu vakada enfeksiyonla ilgili patolojik bir süreç iken, normalde termde olması gereken fizyolojik sürecin erken aktivasyonu ile de olabilir. Önceden preterm doğum yap-mış olmak, sigara, periodontal hastalık, vücut kitle indeksinin düşük olması erken doğum için risk faktörle-ridir. İkinci trimesterde servikal uzunluğun kısalmış olması ve servikovajinal sıvıda fibronektin seviyesinin artması erken doğum tahmininde güvenilir yöntemlerdir. Her ne kadar erken doğumun sonuçlarını iyileştirici yön-temler olsa da erken doğumlarda hedef korunma olmalıdır.

Prediction of preterm delivery

The incidence of preterm birth is increasing and continues to be the leading cause of neonatal mortality and morbidity. Preterm births are regarded as a syndrome resulting from multiple causes, including infection or inflammation, vascular disease and uterine overdistension. The multifactorial aetiology of preterm birth make it difficult to identify the high risked women. Preterm birth is a pathological process, related in the majority of cases to infection, but also the early maturation of physiological processes, that normally occur at term. Risk factors for preterm births include a previous preterm birth, smoking, periodontal disease, low maternal body-mass index. A short cervical length in the second trimester and a raised cervical-vaginal fetal fibronectin concentration can accurately predict early birth. Prevention can be targeted, although effective measures that improve outcome are yet to be established.

___

  • 1.
  • Aygün C, Çetinkaya M, Aydın O, Alper T, Karagöz F, Küçüködük Ş. Ondokuz Mayıs Üniversitesi Tıp Fakültesi 2003 yılı perinatal mortalitesi. Çocuk Sağlığı ve Hastalıkları Dergisi 2007;47: 177-182. 2.
  • McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312: 82-90. 3.
  • Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371: 75-84. 4.
  • Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006;19: 773-82. 5.
  • Marlow N, Wolke D, Bracewell MA, Samara M. EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005;352: 9-19. 6.
  • Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004;103: 551-63. 7.
  • Göksever H, Kılıç B, Erata Y. Epidemiologic factors in preterm birth. Türkiye Klinikleri J Gynecol Obst 2008;18: 294-305. 8.
  • Ananth CV, Getahun D, Peltier MR, Salihu HM, Vintzileos AM. Recurrence of spontaneous versus medically indicated preterm birth. Am J Obstet Gynecol 2006;195: 643-50. 9.
  • Smith GC, Pell JP, Dobbie R. Interpregnancy interval and risk of preterm birth and neonatal death:retrospective cohort study. BMJ 2003; 327: 313. 10.
  • Neggers Y, Goldenberg RL. Some thoughts on body mass index, micronutrient intakes and pregnancy outcome. J Nutr 2003;133: 1737S-1740S. 11.
  • Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000;5: 231-41. 12.
  • Winkvist A, Mogren I, Högberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998;27: 248-54. 13.
  • Kalish RB, Vardhana S, Gupta M, Perni SC, Chasen ST, Witkin SS. Polymorphisms in the tumor necrosis factor-alpha gene at position -308 and the inducible 70 kd heat shock protein gene at position +1267 in multifetal pregnancies and preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2004;191: 1368-74. 14.
  • Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342: 1500-7. 15.
  • Gardella C, Riley DE, Hitti J, Agnew K, Krieger JN, Eschenbach D. Identification and sequencing of bacterial rDNAs in culture-negative amniotic fluid from women in premature labor. Am J Perinatol 2004;21: 319-23. 16.
  • Jalava J, Mäntymaa ML, Ekblad U, Toivanen P, Skurnik M, Lassila O, et al. Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br J Obstet Gynaecol 1996;103: 664-9. 17.
  • Gray DJ, Robinson HB, Malone J, Thomson RB Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12: 111-7. 18.
  • Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93. 19.
  • Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995;173:1231-5. 20.
  • Andrews WW, Goldenberg RL, Mercer B, Iams J, Meis P, Moawad A, et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000;183:662-8. 21.
  • Goldenberg RL, Andrews WW, Yuan AC, MacKay HT, St Louis ME. Sexually transmitted diseases and adverse outcomes of pregnancy. Clin Perinatol 1997;24:23-41. 22.
  • Boggess KA. Pathophysiology of preterm birth: emerging concepts of maternal infection. Clin Perinatol 2005;32: 561-9. 23.
  • Goepfert AR, Jeffcoat MK, Andrews WW, Faye-Petersen O, Cliver SP, Goldenberg RL, et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004; 104: 777-83. 24.
  • Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod 2008;23: 709-15. 25.
  • Gibson CS, Goldwater PN, MacLennan AH, Haan EA, Priest K, Dekker GA. Fetal exposure to herpes viruses may be associated with pregnancy-induced hypertensive disorders and preterm birth in a Caucasian population. BJOG 2008;115: 492-500. 26.
  • McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170: 1048-59. 27.
  • Vidaeff AC, Ramin SM. From concept to practice: the recent history of preterm delivery prevention. Part II: Subclinical infection and hormonal effects. Am J Perinatol 2006;23: 75-84. 28.
  • Hein M, Petersen AC, Helmig RB, Uldbjerg N, Reinholdt J. Immunoglobulin levels and phagocytes in the cervical mucus plug at term of pregnancy. Acta Obstet Gynecol Scand 2005;84: 734-42. 29.
  • Bryant-Greenwood G, Kern A, Yamamoto S, Sadowsky D, Novy M. Relaxin and the human fetal membranes. Reproductive sciences 2007;14: 42-45. 30.
  • Wadhwa PD, Culhane JF, Rauh V, Barve SS. Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms. Matern Child Health J 2001;5: 119-25. 31.
  • Rosen T, Schatz F, Kuczynski E, Lam H, Koo AB, Lockwood CJ. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002;11: 11-7. 32.
  • Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006;113: 17-42. 33.
  • Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980;55: 692-5. 34.
  • Iams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A, et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002;346: 250-5. 35.
  • Groom KM, Shennan AH, Bennett PR. Ultrasound-indicated cervical cerclage: outcome depends on preoperative cervical length and presence of visible membranes at time of cerclage. Am J Obstet Gynecol 2002;187: 445-9. 36.
  • Öcal P, Şal V, Çepni İ, Raşhidova M, Erkan S, Günalp O. Evaluation of risk factors for preterm labour. Türkiye Klinikleri J Gynecol Obstet 2008;18: 161-6. 37.
  • Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. Am J Public Health 1998;88: 233-8. 38.
  • Lockwood CJ, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993; 169: 798-804. 39.
  • Yeast JD, Lu G. Biochemical markers for the prediction of preterm delivery. Clin Perinatol 2007;34: 573-86. 40.
  • Darne J, McGarrigle HH, Lachelin GC. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol: progesterone ratio. Br J Obstet Gynaecol 1987;94: 227-35. 41.
  • Ramsey PS, Andrews WW. Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clin Perinatol 2003;30: 701-33. 42.
  • Onderoğlu LS, Kabukçu A. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynaecol Obstet 1997;56: 245-9. 43.
  • Sanchez-Ramos L, Mentel C, Bertholf R, Kaunitz AM, Delke I, Loge C. Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery. Int J Gynaecol Obstet 2003;83: 151-7. 44.
  • Wenstrom KD, Owen J, Davis RO, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1996;87: 213-6. 45.
  • Tanir HM, Sener T, Yildiz Z. Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes. J Obstet Gynaecol Res 2009;35: 66-72. 46.
  • Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003;101: 847-55.